Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Coronavirus: early-phase trial registry
6 of 21 indexed Coronavirus trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #797 of 28,707 conditions by registered trial count.
21 US clinical trials · 6 currently recruiting · #797 of 28,707 conditions by registered trial count
Coronavirus: 21 US clinical trials tracked, 6 recruiting.
Coronavirus is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 2 of these trials.
Enrollment posture brief
Registry condition coronavirus
OPEN 6 | RECR 29% | LATE 2 | EARLY 7 | RANK #797 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acne Scars (29% recruiting · 7 trials)
Coronavirus lists 6 open slots (29% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Coronavirus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Coronavirus is recruiting below its size-band peers.
6 of 21 indexed trials (28.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Coronavirus trials is spread across many organizations.
Massachusetts General Hospital accounts for 2 of 21 trials (9.5%). 20 distinct sponsors appear on at least one study for this condition label.
-
Typical Coronavirus enrolment sits around 240 participants.
Median target enrolment is 240 among the 21 trials that report a genuine target (sentinel values excluded). 3 of those (14.3%) plan for fewer than 100 participants.
-
Coronavirus splits between interventional and observational designs.
13 interventional and 8 observational studies make up this index (61.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
21 total, page 1 of 1
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
BioFire Defense
NCT07221097
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Columbia University
NCT04367857
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
National Institute of Allergy and Infectious Diseases (NIAID)
NCT04772170
A Study to Explore the Role of Gut Flora in COVID-19 Infection
ProgenaBiome
NCT04359836
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
KidSIM Simulation Program
NCT05868239
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
West Virginia University
NCT04376034
COVID-19 Biorepository
University of Kansas Medical Center
NCT04568148
COVID-19 Health Messaging to Underserved Communities
National Bureau of Economic Research
NCT04371419
Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic
Pregistry
NCT04385238
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
Massachusetts General Hospital
NCT04332991
Evaluation of Antibody Tests for COVID-19
Washington University School of Medicine
NCT04360954
University of Utah COVID-19 Hydrochloroquine Trial
University of Utah
NCT04342169
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning
Dascena
NCT04423991
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19
Massachusetts General Hospital
NCT04306393
Convalescent Plasma to Stem Coronavirus (CSSC-001)
Johns Hopkins University
NCT04323800
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
TriHealth
NCT04392232
NOWDx Test for the Detection of Antibodies to COVID-19
NOWDiagnostics
NCT04690413
Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19
University of Pennsylvania
NCT04379544
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Apellis Pharmaceuticals
NCT04402060
Convalescent Plasma in the Treatment of COVID 19
Trinity Health Of New England
NCT04343261
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
Memorial Sloan Kettering Cancer Center
NCT04824443
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Coronavirus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Coronavirus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Coronavirus page
21 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Coronavirus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Coronavirus trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronavirus condition card totals 21 registered trials; most-linked intervention Hydroxychloroquine; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.